Company Profile

Company Overview

About Noven Pharmaceuticals
Noven Pharmaceuticals, Inc. is a dynamic specialty pharmaceutical company engaged in the research, development, manufacture, marketing and sale of prescription pharmaceutical products. We are committed to developing and offering products and technologies that meaningfully benefit patients, our customers and our industry partners.

Approximately 700 Noven colleagues are working to advance our business and benefit patients at locations in Miami, FL, New York, NY, Carlsbad, CA, and in sales force territories located across the U.S. We are a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., the world’s largest manufacturer of transdermal patches, and we serve as Hisamitsu's growth platform for U.S. prescription pharmaceuticals.

Noven maintains state-of-the art, FDA-approved transdermal manufacturing facilities in Miami and Carlsbad with capacity to produce over 500 million patches per year. These facilities are also approved by the U.S. DEA (Drug Enforcement Agency) for the production of controlled substances.

Noven’s commercialized products and product development activities are principally focused in the areas of women’s health and Central Nervous System (CNS) disorders, including ADHD. Each of these areas is supported by a dedicated, national sale force organized under and managed by our specialty pharmaceutical subsidiary, Noven Therapeutics (NT). For more information on our products and product development pipeline, please visit www.noven.com

Specialties
pharmaceuticals, transdermals, drug delivery, women's health, CNS/ADHD

Headquarters
11960 SW 144th Street Miami, Florida 33186 United States

Website
http://www.noven.com

Industry
Pharmaceuticals